Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Twilio Inc

Start price
Target price
Perf. (%)
€47.70
14.12.22
-
14.12.23
44.26%
15.12.23

buy
TeamViewer AG

Start price
Target price
Perf. (%)
€12.75
14.12.22
-
14.12.23
8.86%
15.12.23

buy
Mandalay Resources Corp.

Start price
Target price
Perf. (%)
€1.94
14.12.22
-
14.12.23
-34.02%
15.12.23

Could be worthwhile Investment >10% per year
buy
SSR Mining Inc.

Start price
Target price
Perf. (%)
€14.73
14.12.22
-
14.12.23
-35.37%
15.12.23

buy
Energy Fuels Inc.

Start price
Target price
Perf. (%)
€5.78
13.12.22
-
13.12.23
8.44%
11.01.23

Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
buy
Uranium Energy Corp

Start price
Target price
Perf. (%)
€3.22
13.12.22
-
13.12.23
14.55%
11.01.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€25.20
13.12.22
€35.00
13.01.23
5.38%
14.01.23

Could be very worthwhile Investment >20% year
Capable Management
Innovative
Good culture
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€165.75
13.12.22
€170.00
13.12.23
5.61%
15.12.22

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
Hornbach Baumarkt AG

Start price
Target price
Perf. (%)
€47.50
13.12.22
€50.00
-
23.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Boss Energy Ltd.

Start price
Target price
Perf. (%)
€1.41
13.12.22
-
13.12.23
13.22%
10.02.23

Could be very worthwhile Investment >20% year
buy
Surgepays Inc.

Start price
Target price
Perf. (%)
€6.85
13.12.22
€14.00
13.12.23
-8.76%
26.12.22

Could be very worthwhile Investment >20% year
buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.20
13.12.22
€1.30
13.12.23
9.03%
14.12.23

Could be very worthwhile Investment >20% year
buy
American Water Works Corp. Inc.

Start price
Target price
Perf. (%)
€149.68
13.12.22
€155.00
13.12.23
-19.56%
17.11.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
buy
Deutsche Rohstoff AG

Start price
Target price
Perf. (%)
€25.40
13.12.22
-
13.12.23
27.17%
14.12.23

buy
CropEnergies AG

Start price
Target price
Perf. (%)
€13.34
13.12.22
-
13.12.23
-47.23%
14.12.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Growths much faster than the competition
Very Future proof/growth oriented business model
buy
Consolidated Uranium Inc.

Start price
Target price
Perf. (%)
€1.08
13.12.22
-
13.12.23
17.21%
11.01.23

Could be very worthwhile Investment >20% year
buy
Isoenergy Ltd

Start price
Target price
Perf. (%)
€2.11
13.12.22
-
13.12.23
16.37%
29.08.23

Could be very worthwhile Investment >20% year
buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€6.38
12.12.22
€10.00
08.12.23
-3.73%
14.12.22

EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Navya S.a.

Start price
Target price
Perf. (%)
€0.14
12.12.22
€0.20
12.12.23
-73.14%
22.12.22

Could be worthwhile Investment >10% per year
Spineway

Start price
Target price
Perf. (%)
€2.20
12.12.22
-
12.12.23
-61.36%
24.04.23

Risky Investment
Growths slower than the competition
buy
Eni SpA

Start price
Target price
Perf. (%)
€13.46
12.12.22
€15.00
12.12.23
1.52%
14.12.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
buy
OMV AG

Start price
Target price
Perf. (%)
€46.70
12.12.22
€48.00
12.12.23
6.17%
24.12.22

Could be very worthwhile Investment >20% year
Fair valuation
Good rating
Standard Investments for future growth
buy
Shell plc

Start price
Target price
Perf. (%)
€26.48
12.12.22
€27.00
12.12.23
4.61%
08.02.23

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
€0.000
12.12.23
-63.50%
15.12.22

Capable Management
Risky Investment
No uniques
No Innovation
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.39
12.12.22
€7.00
12.12.23
-60.16%
24.12.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Little innovation